Efficacy News and Research

RSS
HemoShear completes first-phase development of novel cancer drug discovery platform

HemoShear completes first-phase development of novel cancer drug discovery platform

CytRx begins Phase 1b trial of aldoxorubicin plus gemcitabine in patients with metastatic solid tumors

CytRx begins Phase 1b trial of aldoxorubicin plus gemcitabine in patients with metastatic solid tumors

Higher doses of neuroleptics needed for pregnant women with psychiatric conditions

Higher doses of neuroleptics needed for pregnant women with psychiatric conditions

Isavuconazole demonstrates successful outcomes in treatment of mucormycosis

Isavuconazole demonstrates successful outcomes in treatment of mucormycosis

Ruthigen begins Phase 1/2 clinical trial of RUT58-60

Ruthigen begins Phase 1/2 clinical trial of RUT58-60

Combination of behavioral support and medication helps people stop smoking

Combination of behavioral support and medication helps people stop smoking

Research finding could potentially lead to new strategies to improve cancer therapies

Research finding could potentially lead to new strategies to improve cancer therapies

New partners join Grand Challenges Canada to help protect early brain development

New partners join Grand Challenges Canada to help protect early brain development

G-tube placement not needed for patients with advanced dementia or other near end-of-life conditions

G-tube placement not needed for patients with advanced dementia or other near end-of-life conditions

Two randomized trials examine new vaccination strategies for avian influenza

Two randomized trials examine new vaccination strategies for avian influenza

GeneSolve to license its health optimization system to highly qualified doctors

GeneSolve to license its health optimization system to highly qualified doctors

Cardiac Dimensions adds $8.5M to its previously announced financing

Cardiac Dimensions adds $8.5M to its previously announced financing

Pinnacle initiates pivotal Phase 3 trial in Germany for rare form of bile duct cancer

Pinnacle initiates pivotal Phase 3 trial in Germany for rare form of bile duct cancer

Study: Vaccines targeting adults, teens could potentially eliminate TB by 2050

Study: Vaccines targeting adults, teens could potentially eliminate TB by 2050

Researchers launch landmark new program to explore potential impact of medical marijuana

Researchers launch landmark new program to explore potential impact of medical marijuana

AfriCoLeish launches Phase III clinical study to test 2 treatments for HIV-VL co-infected patients

AfriCoLeish launches Phase III clinical study to test 2 treatments for HIV-VL co-infected patients

Eli Lilly to discontinue development of tabalumab due to insufficient efficacy in Phase 3 Lupus trials

Eli Lilly to discontinue development of tabalumab due to insufficient efficacy in Phase 3 Lupus trials

Humalog 200 units/ml KwikPen insulin gets marketing approval in EU for treatment of diabetes

Humalog 200 units/ml KwikPen insulin gets marketing approval in EU for treatment of diabetes

BIDMC receives $20 million grant to evaluate, test monoclonal antibodies for HIV treatment

BIDMC receives $20 million grant to evaluate, test monoclonal antibodies for HIV treatment

NKT Therapeutics' NKTT120 receives FDA Fast Track designation for treatment of sickle cell disease

NKT Therapeutics' NKTT120 receives FDA Fast Track designation for treatment of sickle cell disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.